JACOB GARY S Insider Trading Activity

Average Profitability
122.37%
Insider Buys Quantity
3
Insider Buys Sum
$99,690.04
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of JACOB GARY S

According to the SEC Form 4 filings, JACOB GARY S, being in a position of

  1. CHIEF DEVELOPMENT OFFICER at OKYO Pharma Limited,
    оver the last 12 months, has bought 3500 shares for $4,900, and sold 0 shares,
    over all time since 2022-05-19, has bought 16000 shares for $54,900, and sold 0 shares.

Biography of JACOB GARY S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $4,9001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-07-21PurchaseOKYO Pharma Limited
OKYO
CHIEF DEVELOPMENT OFFICER
3,500
0.0089%
$1.40$4,900+3.13%
2022-05-19PurchaseOKYO Pharma Limited
OKYO
Chief Executive Officer
12,500
0.1445%
$4.00$50,000-36.04%
2021-03-23PurchaseCardiff Oncology, Inc.
CRDF
director
2,370
0.0066%
$10.42$24,689-37.74%
2020-05-14PurchaseCardiff Oncology, Inc.
CRDF
director
17,483
0.1206%
$1.43$25,001+599.3%
Total: 4
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.